Intensive Strength Training in Children With Cerebral Palsy - Effect on Hand Function

The objective of this study is to gain more knowledge about the association between muscle weakness, spasticity and motor control in children with cerebral palsy, and its relationship to hand function.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cerebral Palsy Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases

Age range

10 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

St. Olavs Hospital

Trondheim, 7004, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosed spastic hemiplegic or diplegic cerebral palsy, reduced handfunction.
Indication for treatment with Botulinum Toxin A
Score 3 on House Classification of Upper-Extremity Functional Use
Score 3 or better on Manual Ability Classification System

Exclusion criteria

surgery within the last two years
Treatment with Botulinum Toxin within the last six months

Treatment and study plan

Botulinum toxin A

Drug

Other names: Botox, BoNT A

Resistance training

Behavioral

Other names: Strength training

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Collaborators

Norwegian University of Science and Technology

Registry information

Important dates

Study start: 2006
Primary completion: 2007
Study completion: 2008
First posted: Apr 30, 2007
Registry last updated: Apr 18, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed